Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Net Debt / EBITDA

Albireo Pharma Inc Net Debt / EBITDA Chart (ALBO)

Albireo Pharma Inc annual/quarterly Net Debt / EBITDA from 2015 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Albireo Pharma Inc Net Debt / EBITDA for the quarter ending June 06, 2020 was $2m a 11.40% increase of 0m year over year
  • Albireo Pharma Inc Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $2m a -18.94% decrease of 0m year over year
  • Albireo Pharma Inc Annual Net Debt / EBITDA for 2019 was $2m a -105.33% decrease of -2m from 2018
  • Albireo Pharma Inc Annual Net Debt / EBITDA for 2018 was $4m a 56.15% increase of 2m from 2017
  • Albireo Pharma Inc Annual Net Debt / EBITDA for 2017 was $2m a -112.43% decrease of -2m from 2016
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO Net Debt / EBITDA Data

06/2020$2m
03/2020$1m
12/2019$3m
09/2019$2m
06/2019$3m
03/2019$2m
12/2018$3m
09/2018$3m
06/2018$4m
03/2018$91m

Annual ALBO Net Debt / EBITDA Data

2019$2m
2018$4m
2017$2m
2016$4m
2015$0m
2014$0m